Predicting the outcomes of hepatocellular carcinoma downstaging with the use of clinical and radiomics features

Prognostic models for outcome prediction in patients with advanced hepatocellular carcinoma treated by systemic therapy: A systematic review and critical appraisal

17 p | 8 | 4

Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy

10 p | 17 | 3

Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma

9 p | 9 | 2

Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma

11 p | 11 | 2

Prognostic nomogram for hepatocellular carcinoma with radiofrequency ablation: A retrospective cohort study

13 p | 8 | 2

Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: The role of surgical or nonsurgical methods

14 p | 11 | 1

The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: Implications for clinical management

8 p | 11 | 1

Predictive factors of treatment outcomes after percutaneous ablation of hepatocellular carcinoma in the caudate lobe: A retrospective study

13 p | 14 | 1

Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma

10 p | 11 | 0